Union Health Minister Mansukh Mandaviya, who chaired a meeting of the country's key experts on the new XE variant' of coronavirus, directed officials to boost the ongoing monitoring and surveillance of new variants and cases.
He also asked the officials to constantly review the availability of essential drugs and medicines required in the treatment of COVID-19 patients, a statement from the ministry read.
The minister further emphasized on carrying out the ongoing vaccination drive at full pace and to vaccinate all eligible candidates, the statement said.
The meeting was attended by Dr VK Paul, Member (Health), NITI Ayog; Rajesh Bhushan, Secretary, Health; Dr Randip Guleria, Director, AIIMS; Dr Balrama Bhargava, Director General, ICMR; Dr. N K Arora, chief of National Technical Advisory Group on Immunisation in India, and other senior officials of the health ministry.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU